Geographic Information Systems and Science for Cancer Control

Geographic Boundary Information

  • County
  • Counties change over time so when looking at data across time periods, some counties may need to be grouped to get valid results. There are over 3000 counties in the United States.

  • Health Service Areas (HSA)
  • Health Service Areas (HSAs) were originally defined by the National Center for Health Statistics, part of the Centers for Disease Control and Prevention, to be a single county or cluster of contiguous counties which are relatively self-contained with respect to hospital care. For further information about their initial use, please visit the Atlas of United States Mortality.

    These HSAs have been modified so that none of the HSAs cross state boundaries. These are referred to as HSAs (NCI Modified). There are over 900 HSAs in the United States.

  • State Economic Areas (SEA)
  • State Economic Areas were originally defined by the Census Bureau in 1960. SEAs are individual counties or groups of counties that are relatively homogenous with respect to various demographic, economic, and cultural factors. There are over 500 SEAs in the United States.

  • State

Return to Top


NCI Cancer Atlas Data Sources

This page contains information on the following data sources:


Demographics:

  • US by County 2012 to 2016

  • US by HSA 2012 to 2016

  • US by SEA 2012 to 2016

  • US by State 2012 to 2016


  • Data is available for the following topic and variable combinations:

    • Crowding
      • Households with >1 person per room (Both Sexes) [Percent]
      • Households with >1 person per room (Both Sexes) [Total Count]
    • Education
      • Less than 9th grade (Both Sexes) [Percent]
      • Less than 9th grade (Both Sexes) [Total Count]
      • Less than HS (Both Sexes) [Percent]
      • Less than HS (Both Sexes) [Total Count]
      • At Least Bachelors Degree (Both Sexes) [Percent]
      • At Least Bachelors Degree (Both Sexes) [Total Count]
    • Income
      • Median Family Income (Both Sexes) [Dollars]
      • Median Family Income (Both Sexes) [Total Count]
      • Median Household Income (Both Sexes) [Dollars]
      • Median Household Income (Both Sexes) [Total Count]
    • Insurance
      • Uninsured among Those at or below 138% of Poverty (Both Sexes - Ages <65 -2016) [Percent]
      • Uninsured among Those at or below 138% of Poverty (Both Sexes - Ages <65 -2016) [Total Count]
      • Uninsured among Those at or below 138% of Poverty (Both Sexes - Ages <19 -2016) [Percent]
      • Uninsured among Those at or below 138% of Poverty (Both Sexes - Ages <19 -2016) [Total Count]
      • Uninsured among Those at or below 138% of Poverty (Females - Ages <65 -2016) [Percent]
      • Uninsured among Those at or below 138% of Poverty (Females - Ages <65 -2016) [Total Count]
      • Uninsured among Those at or below 138% of Poverty (Males - Ages <65 -2016) [Percent]
      • Uninsured among Those at or below 138% of Poverty (Males - Ages <65 -2016) [Total Count]
    • Mobility
      • Haven't Moved (in Past Year) (Both Sexes - Ages 1+) [Percent]
      • Haven't Moved (in Past Year) (Both Sexes - Ages 1+) [Total Count]
      • Moved, Same County (in Past Year) (Both Sexes - Ages 1+) [Percent]
      • Moved, Same County (in Past Year) (Both Sexes - Ages 1+) [Total Count]
      • Moved, Different County, Same State (in Past Year) (Both Sexes - Ages 1+) [Percent]
      • Moved, Different County, Same State (in Past Year) (Both Sexes - Ages 1+) [Total Count]
      • Moved, Different State (in Past Year) (Both Sexes - Ages 1+) [Percent]
      • Moved, Different State (in Past Year) (Both Sexes - Ages 1+) [Total Count]
      • Moved from outside US (in Past Year) (Both Sexes - Ages 1+) [Percent]
      • Moved from outside US (in Past Year) (Both Sexes - Ages 1+) [Total Count]
    • Non-English Language
      • Language Isolation (Both Sexes - Ages 14+) [Percent]
      • Language Isolation (Both Sexes - Ages 14+) [Total Count]
    • Population
      • Age 40 and Over (Both Sexes) [Percent]
      • Age 40 and Over (Both Sexes) [Total Count]
      • Age 50 and Over (Both Sexes) [Percent]
      • Age 50 and Over (Both Sexes) [Total Count]
      • Age 65 and Over (Both Sexes) [Percent]
      • Age 65 and Over (Both Sexes) [Total Count]
      • Foreign Born (Both Sexes) [Percent]
      • Foreign Born (Both Sexes) [Total Count]
      • American Indian/Alaska Native (Both Sexes) [Percent]
      • American Indian/Alaska Native (Both Sexes) [Total Count]
      • Asian/Pacific Islander (Both Sexes) [Percent]
      • Asian/Pacific Islander (Both Sexes) [Total Count]
      • Black (Both Sexes) [Percent]
      • Black (Both Sexes) [Total Count]
      • Hispanic (Both Sexes) [Percent]
      • Hispanic (Both Sexes) [Total Count]
      • White (Both Sexes) [Percent]
      • White (Both Sexes) [Total Count]
    • Poverty
      • Families Below Poverty (Both Sexes) [Percent]
      • Families Below Poverty (Both Sexes) [Total Count]
      • Persons Below Poverty (Both Sexes) [Percent]
      • Persons Below Poverty (Both Sexes) [Total Count]
      • Persons <150% of Poverty (Both Sexes) [Percent]
      • Persons <150% of Poverty (Both Sexes) [Total Count]
      • At or below 138% of Poverty (Both Sexes - Ages <65 -2016) [Percent]
      • At or below 138% of Poverty (Both Sexes - Ages <65 -2016) [Total Count]
      • At or below 138% of Poverty (Both Sexes - Ages <19 -2016) [Percent]
      • At or below 138% of Poverty (Both Sexes - Ages <19 -2016) [Total Count]
      • At or below 138% of Poverty (Females - Ages <65 -2016) [Percent]
      • At or below 138% of Poverty (Females - Ages <65 -2016) [Total Count]
      • At or below 138% of Poverty (Males - Ages <65 -2016) [Percent]
      • At or below 138% of Poverty (Males - Ages <65 -2016) [Total Count]
    • Workforce
      • Unemployed (Both Sexes - Ages 16+) [Percent]
      • Unemployed (Both Sexes - Ages 16+) [Total Count]

    Source:

    Demographic estimates are provided by the Census Bureau from the American Community Survey and Small Area Health Insurance Estimates.

    Suppressed / Not Available:

    All data is shown that is available.

Return to Top


Historical Mortality:

  • US by County 1970 to 1979

  • US by County 1980 to 1989

  • US by County 1990 to 1999

  • US by County 2000 to 2009

  • US by HSA 1970 to 1979

  • US by HSA 1980 to 1989

  • US by HSA 1990 to 1999

  • US by HSA 2000 to 2009

  • US by SEA 1970 to 1979

  • US by SEA 1980 to 1989

  • US by SEA 1990 to 1999

  • US by SEA 2000 to 2009

  • US by State 1970 to 1979

  • US by State 1980 to 1989

  • US by State 1990 to 1999

  • US by State 2000 to 2009


Data is available for the following racial/ethnic groups from 1970 to 1989:

  • All Races
  • Black
  • White including Hispanic

Data is available for the following racial/ethnic groups from 1990 to 2009:

  • All Races
  • American Indian/Alaskan Native
  • Asian Pacific Islander
  • Black
  • Hispanic
  • White Hispanic
  • White Non-Hispanic
  • White including Hispanic

Data for the following variables is available for each race category:

  • All Causes of Death (Both Sexes) [Rate per 100,000]
  • All Causes of Death (Male) [Rate per 100,000]
  • All Causes of Death (Female) [Rate per 100,000]
  • All Malignant Cancers (Both Sexes) [Rate per 100,000]
  • All Malignant Cancers (Male) [Rate per 100,000]
  • All Malignant Cancers (Female) [Rate per 100,000]
  • Anus, Anal Canal & Anorectum (Both Sexes) [Rate per 100,000]
  • Anus, Anal Canal & Anorectum (Male) [Rate per 100,000]
  • Anus, Anal Canal & Anorectum (Female) [Rate per 100,000]
  • Bladder (Both Sexes) [Rate per 100,000]
  • Bladder (Male) [Rate per 100,000]
  • Bladder (Female) [Rate per 100,000]
  • Bones and Joints (Both Sexes) [Rate per 100,000]
  • Bones and Joints (Male) [Rate per 100,000]
  • Bones and Joints (Female) [Rate per 100,000]
  • Brain and Other Nervous System (Both Sexes) [Rate per 100,000]
  • Brain and Other Nervous System (Male) [Rate per 100,000]
  • Brain and Other Nervous System (Female) [Rate per 100,000]
  • Breast (Female) [Rate per 100,000]
  • Cervix Uteri (Female) [Rate per 100,000]
  • Childhood (Ages <15) (Both Sexes) [Rate per 100,000]
  • Childhood (Ages <15) (Male) [Rate per 100,000]
  • Childhood (Ages <15) (Female) [Rate per 100,000]
  • Childhood (Ages <20) (Both Sexes) [Rate per 100,000]
  • Childhood (Ages <20) (Male) [Rate per 100,000]
  • Childhood (Ages <20) (Female) [Rate per 100,000]
  • Colon and Rectum (Both Sexes) [Rate per 100,000]
  • Colon and Rectum (Male) [Rate per 100,000]
  • Colon and Rectum (Female) [Rate per 100,000]
  •     Colon (Both Sexes) [Rate per 100,000]
  •     Colon (Male) [Rate per 100,000]
  •     Colon (Female) [Rate per 100,000]
  •     Rectum (and Rectosigmoid) (Both Sexes) [Rate per 100,000]
  •     Rectum (and Rectosigmoid) (Male) [Rate per 100,000]
  •     Rectum (and Rectosigmoid) (Female) [Rate per 100,000]
  • Corpus and Uterus,NOS (Female) [Rate per 100,000]
  • Esophagus (Both Sexes) [Rate per 100,000]
  • Esophagus (Male) [Rate per 100,000]
  • Esophagus (Female) [Rate per 100,000]
  • Eye and Orbit (Both Sexes) [Rate per 100,000]
  • Eye and Orbit (Male) [Rate per 100,000]
  • Eye and Orbit (Female) [Rate per 100,000]
  • Gallbladder (Both Sexes) [Rate per 100,000]
  • Gallbladder (Male) [Rate per 100,000]
  • Gallbladder (Female) [Rate per 100,000]
  • Hodgkin Lymphoma (Both Sexes) [Rate per 100,000]
  • Hodgkin Lymphoma (Male) [Rate per 100,000]
  • Hodgkin Lymphoma (Female) [Rate per 100,000]
  • Kidney and Renal Pelvis (Both Sexes) [Rate per 100,000]
  • Kidney and Renal Pelvis (Male) [Rate per 100,000]
  • Kidney and Renal Pelvis (Female) [Rate per 100,000]
  • Larynx (Both Sexes) [Rate per 100,000]
  • Larynx (Male) [Rate per 100,000]
  • Larynx (Female) [Rate per 100,000]
  • Leukemia
  • Leukemia
  • Leukemia
  •     Lymphocytic Leukemia (Both Sexes) [Rate per 100,000]
  •     Lymphocytic Leukemia (Male) [Rate per 100,000]
  •     Lymphocytic Leukemia (Female) [Rate per 100,000]
  •     Acute Lymphocytic Leukemia (Both Sexes) [Rate per 100,000]
  •     Acute Lymphocytic Leukemia (Male) [Rate per 100,000]
  •     Acute Lymphocytic Leukemia (Female) [Rate per 100,000]
  •     Chronic Lymphocytic Leukemia (Both Sexes) [Rate per 100,000]
  •     Chronic Lymphocytic Leukemia (Male) [Rate per 100,000]
  •     Chronic Lymphocytic Leukemia (Female) [Rate per 100,000]
  •     Myeloid and Moncytic Leukemia (Both Sexes) [Rate per 100,000]
  •     Myeloid and Moncytic Leukemia (Male) [Rate per 100,000]
  •     Myeloid and Moncytic Leukemia (Female) [Rate per 100,000]
  •     Acute Moncytic Leukemia (Both Sexes) [Rate per 100,000]
  •     Acute Moncytic Leukemia (Male) [Rate per 100,000]
  •     Acute Moncytic Leukemia (Female) [Rate per 100,000]
  •     Acute Myeloid Leukemia (Both Sexes) [Rate per 100,000]
  •     Acute Myeloid Leukemia (Male) [Rate per 100,000]
  •     Acute Myeloid Leukemia (Female) [Rate per 100,000]
  •     Chronic Myeloid Leukemia (Both Sexes) [Rate per 100,000]
  •     Chronic Myeloid Leukemia (Male) [Rate per 100,000]
  •     Chronic Myeloid Leukemia (Female) [Rate per 100,000]
  • Liver and Intrahepatic Bile Duct (Both Sexes) [Rate per 100,000]
  • Liver and Intrahepatic Bile Duct (Male) [Rate per 100,000]
  • Liver and Intrahepatic Bile Duct (Female) [Rate per 100,000]
  • Lung and Bronchus (Both Sexes) [Rate per 100,000]
  • Lung and Bronchus (Male) [Rate per 100,000]
  • Lung and Bronchus (Female) [Rate per 100,000]
  • Melanoma of the Skin (Both Sexes) [Rate per 100,000]
  • Melanoma of the Skin (Male) [Rate per 100,000]
  • Melanoma of the Skin (Female) [Rate per 100,000]
  • Myeloma (Both Sexes) [Rate per 100,000]
  • Myeloma (Male) [Rate per 100,000]
  • Myeloma (Female) [Rate per 100,000]
  • Non-Hodgkin Lymphoma (Both Sexes) [Rate per 100,000]
  • Non-Hodgkin Lymphoma (Male) [Rate per 100,000]
  • Non-Hodgkin Lymphoma (Female) [Rate per 100,000]
  • Nose, Nasal Cavity and Middle Ear (Both Sexes) [Rate per 100,000]
  • Nose, Nasal Cavity and Middle Ear (Male) [Rate per 100,000]
  • Nose, Nasal Cavity and Middle Ear (Female) [Rate per 100,000]
  • Oral Cavity and Pharynx (Both Sexes) [Rate per 100,000]
  • Oral Cavity and Pharynx (Male) [Rate per 100,000]
  • Oral Cavity and Pharynx (Female) [Rate per 100,000]
  •     Floor of Mouth (Both Sexes) [Rate per 100,000]
  •     Floor of Mouth (Male) [Rate per 100,000]
  •     Floor of Mouth (Female) [Rate per 100,000]
  •     Gum and Other Mouth (Both Sexes) [Rate per 100,000]
  •     Gum and Other Mouth (Male) [Rate per 100,000]
  •     Gum and Other Mouth (Female) [Rate per 100,000]
  •     Lip (Both Sexes) [Rate per 100,000]
  •     Lip (Male) [Rate per 100,000]
  •     Lip (Female) [Rate per 100,000]
  •     Oropharynx and Tonsil (Both Sexes) [Rate per 100,000]
  •     Oropharynx and Tonsil (Male) [Rate per 100,000]
  •     Oropharynx and Tonsil (Female) [Rate per 100,000]
  •     Salivary Gland (Both Sexes) [Rate per 100,000]
  •     Salivary Gland (Male) [Rate per 100,000]
  •     Salivary Gland (Female) [Rate per 100,000]
  •     Tongue (Both Sexes) [Rate per 100,000]
  •     Tongue (Male) [Rate per 100,000]
  •     Tongue (Female) [Rate per 100,000]
  • Ovary (Female) [Rate per 100,000]
  • Pancreas (Both Sexes) [Rate per 100,000]
  • Pancreas (Male) [Rate per 100,000]
  • Pancreas (Female) [Rate per 100,000]
  • Penis (Male) [Rate per 100,000]
  • Prostate (Male) [Rate per 100,000]
  • Small Intestine (Both Sexes) [Rate per 100,000]
  • Small Intestine (Male) [Rate per 100,000]
  • Small Intestine (Female) [Rate per 100,000]
  • Soft Tissue including Heart (Both Sexes) [Rate per 100,000]
  • Soft Tissue including Heart (Male) [Rate per 100,000]
  • Soft Tissue including Heart (Female) [Rate per 100,000]
  • Stomach (Both Sexes) [Rate per 100,000]
  • Stomach (Male) [Rate per 100,000]
  • Stomach (Female) [Rate per 100,000]
  • Testis (Male) [Rate per 100,000]
  • Thyroid (Both Sexes) [Rate per 100,000]
  • Thyroid (Male) [Rate per 100,000]
  • Thyroid (Female) [Rate per 100,000]
  • Vagina (Female) [Rate per 100,000]
  • Vulva (Female) [Rate per 100,000]
  • Miscellaneous Malignant Cancer (Both Sexes) [Rate per 100,000]
  • Miscellaneous Malignant Cancer (Male) [Rate per 100,000]
  • Miscellaneous Malignant Cancer (Female) [Rate per 100,000]

Source:

Death data provided by the National Vital Statistics System public use data file. Death rates are calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+).

Suppressed / Not Available:

Data are suppressed if the total count < 16 for the time period.

Data on Hispanic origin was not collected for Louisiana in 1990, New Hampshire in 1990-1992, and Oklahoma in 1990-1996. In accordance with NCHS policy, 1990-1999 mortality data is not available for these states.

Return to Top


Incidence:

  • US State 2011 to 2015

  • US County 2011 to 2015


  • Data is available for the following racial/ethnic groups:

    • All Races
    • American Indian/Alaskan Native
    • Asian Pacific Islander
    • Black
    • Hispanic
    • White Non-Hispanic
    • White including Hispanic
    • White Hispanic

    Data for the following variables is available for each race category:

    • All Cancer Sites (Both Sexes)
    • Bladder (Both Sexes)
    • Brain & ONS (Both Sexes)
    • Childhood (Ages <15, All Sites) (Both Sexes)
    • Childhood (Ages <20, All Sites) (Both Sexes)
    • Colon & Rectum (Both Sexes)
    • Esophagus (Both Sexes)
    • Kidney & Renal Pelvis (Both Sexes)
    • Leukemia (Both Sexes)
    • Liver & Bile Duct (Both Sexes)
    • Lung & Bronchus (Both Sexes)
    • Melanoma of the Skin (Both Sexes)
    • Non-Hodgkin Lymphoma (Both Sexes)
    • Oral Cavity & Pharynx (Both Sexes)
    • Pancreas (Both Sexes)
    • Stomach (Both Sexes)
    • Thyroid (Both Sexes)

    • All Cancer Sites (Female)
    • Bladder (Female)
    • Brain & ONS (Female)
    • Breast (Female)
    • Cervix (Female)
    • Childhood (Ages <15, All Sites) (Female)
    • Childhood (Ages <20, All Sites) (Female)
    • Colon & Rectum (Female)
    • Esophagus (Female)
    • Kidney & Renal Pelvis (Female)
    • Leukemia (Female)
    • Liver & Bile Duct (Female)
    • Lung & Bronchus (Female)
    • Melanoma of the Skin (Female)
    • Non-Hodgkin Lymphoma (Female)
    • Oral Cavity & Pharynx (Female)
    • Ovary (Female)
    • Pancreas (Female)
    • Stomach (Female)
    • Thyroid (Female)
    • Uterus (Female)

    • All Cancers (Male)
    • Bladder (Male)
    • Brain & ONS (Male)
    • Childhood (Ages <15, All Sites) (Male)
    • Childhood (Ages <20, All Sites) (Male)
    • Colon & Rectum (Male)
    • Esophagus (Male)
    • Kidney & Renal Pelvis (Male)
    • Leukemia (Male)
    • Liver & Bile Duct (Male)
    • Lung & Bronchus (Male)
    • Melanoma of the Skin (Male)
    • Non-Hodgkin Lymphoma (Male)
    • Oral Cavity & Pharynx (Male)
    • Pancreas (Male)
    • Prostate (Male)
    • Stomach (Male)
    • Thyroid (Male)

    Source:

    CDC's National Program of Cancer Registries Cancer Surveillance System (NPCR-CSS) January 2017 data submission and SEER November 2012 submission (seer.cancer.gov). Incidence rates are calculated by the National Cancer Institute using SEER*Stat. Incidence rates are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+).

    Suppressed / Not Available:

    Data are suppressed if the total count < 16 for the time period.

      The data for the following states are not available by state or county:

      • Nevada

      The data for the following states are not available by county:

      • Kansas
      • Minnesota

      American Indian/Alaska Native data for the following states are not available by state or county for:

      • Delaware
      • Illinois
      • Kansas
      • Kentucky
      • New Jersey
      • New York
      • South Carolina

      Asian/Pacific Islander data for the following states are not available by state or county for:

      • Delaware
      • Illinois
      • Kentucky
      • South Carolina

      Hispanic data for the following states are not available by state or county for:

      • Delaware
      • Illinois
      • Kentucky
      • Massachusetts
      • Pennsylvania
      • South Carolina

      Data for the NPCR Registries is not available for white Hispanics and white non-Hispanics.

Return to Top


Mortality:

  • US by County 2011 to 2015

  • US by HSA 2011 to 2015

  • US by SEA 2011 to 2015

  • US by State 2011 to 2015


  • Data is available for the following racial/ethnic groups:

    • All Races
    • American Indian/Alaskan Native
    • Asian Pacific Islander
    • Black
    • Hispanic
    • White Non-Hispanic
    • White including Hispanic
    • White Hispanic

    Data for the following variables is available for each race category:

    • All Causes of Death (Both Sexes) [CI and Count]
    • All Causes of Death (Male) [CI and Count]
    • All Causes of Death (Female) [CI and Count]
    • All Malignant Cancers (Both Sexes) [CI and Count]
    • All Malignant Cancers (Male) [CI and Count]
    • All Malignant Cancers (Female) [CI and Count]
    • Anus, Anal Canal & Anorectum (Both Sexes) [CI and Count]
    • Anus, Anal Canal & Anorectum (Male) [CI and Count]
    • Anus, Anal Canal & Anorectum (Female) [CI and Count]
    • Bladder (Both Sexes) [CI and Count]
    • Bladder (Male) [CI and Count]
    • Bladder (Female) [CI and Count]
    • Bones and Joints (Both Sexes) [CI and Count]
    • Bones and Joints (Male) [CI and Count]
    • Bones and Joints (Female) [CI and Count]
    • Brain and Other Nervous System (Both Sexes) [CI and Count]
    • Brain and Other Nervous System (Male) [CI and Count]
    • Brain and Other Nervous System (Female) [CI and Count]
    • Breast (Female) [CI and Count]
    • Cervix Uteri (Female) [CI and Count]
    • Childhood (Ages <15) (Both Sexes) [CI and Count]
    • Childhood (Ages <15) (Male) [CI and Count]
    • Childhood (Ages <15) (Female) [CI and Count]
    • Childhood (Ages <20) (Both Sexes) [CI and Count]
    • Childhood (Ages <20) (Male) [CI and Count]
    • Childhood (Ages <20) (Female) [CI and Count]
    • Colon and Rectum (Both Sexes) [CI and Count]
    • Colon and Rectum (Male) [CI and Count]
    • Colon and Rectum (Female) [CI and Count]
    • Colon (Both Sexes) [CI and Count]
    • Colon (Male) [CI and Count]
    • Colon (Female) [CI and Count]
    • Rectum (and Rectosigmoid) (Both Sexes) [CI and Count]
    • Rectum (and Rectosigmoid) (Male) [CI and Count]
    • Rectum (and Rectosigmoid) (Female) [CI and Count]
    • Corpus and Uterus,NOS (Female) [CI and Count]
    • Esophagus (Both Sexes) [CI and Count]
    • Esophagus (Male) [CI and Count]
    • Esophagus (Female) [CI and Count]
    • Eye and Orbit (Both Sexes) [CI and Count]
    • Eye and Orbit (Male) [CI and Count]
    • Eye and Orbit (Female) [CI and Count]
    • Gallbladder (Both Sexes) [CI and Count]
    • Gallbladder (Male) [CI and Count]
    • Gallbladder (Female) [CI and Count]
    • Hodgkin Lymphoma (Both Sexes) [CI and Count]
    • Hodgkin Lymphoma (Male) [CI and Count]
    • Hodgkin Lymphoma (Female) [CI and Count]
    • Kidney and Renal Pelvis (Both Sexes) [CI and Count]
    • Kidney and Renal Pelvis (Male) [CI and Count]
    • Kidney and Renal Pelvis (Female) [CI and Count]
    • Larynx (Both Sexes) [CI and Count]
    • Larynx (Male) [CI and Count]
    • Larynx (Female) [CI and Count]
    • Leukemia: Total (Both Sexes) [CI and Count]
    • Leukemia: Total (Male) [CI and Count]
    • Leukemia: Total (Female) [CI and Count]
    • Lymphocytic Leukemia (Both Sexes) [CI and Count]
    • Lymphocytic Leukemia (Male) [CI and Count]
    • Lymphocytic Leukemia (Female) [CI and Count]
    • Acute Lymphocytic Leukemia (Both Sexes) [CI and Count]
    • Acute Lymphocytic Leukemia (Male) [CI and Count]
    • Acute Lymphocytic Leukemia (Female) [CI and Count]
    • Chronic Lymphocytic Leukemia (Both Sexes) [CI and Count]
    • Chronic Lymphocytic Leukemia (Male) [CI and Count]
    • Chronic Lymphocytic Leukemia (Female) [CI and Count]
    • Myeloid and Moncytic Leukemia (Both Sexes) [CI and Count]
    • Myeloid and Moncytic Leukemia (Male) [CI and Count]
    • Myeloid and Moncytic Leukemia (Female) [CI and Count]
    • Acute Moncytic Leukemia (Both Sexes) [CI and Count]
    • Acute Moncytic Leukemia (Male) [CI and Count]
    • Acute Moncytic Leukemia (Female) [CI and Count]
    • Acute Myeloid Leukemia (Both Sexes) [CI and Count]
    • Acute Myeloid Leukemia (Male) [CI and Count]
    • Acute Myeloid Leukemia (Female) [CI and Count]
    • Chronic Myeloid Leukemia (Both Sexes) [CI and Count]
    • Chronic Myeloid Leukemia (Male) [CI and Count]
    • Chronic Myeloid Leukemia (Female) [CI and Count]
    • Liver and Intrahepatic Bile Duct (Both Sexes) [CI and Count]
    • Liver and Intrahepatic Bile Duct (Male) [CI and Count]
    • Liver and Intrahepatic Bile Duct (Female) [CI and Count]
    • Lung and Bronchus (Both Sexes) [CI and Count]
    • Lung and Bronchus (Male) [CI and Count]
    • Lung and Bronchus (Female) [CI and Count]
    • Melanoma of the Skin (Both Sexes) [CI and Count]
    • Melanoma of the Skin (Male) [CI and Count]
    • Melanoma of the Skin (Female) [CI and Count]
    • Myeloma (Both Sexes) [CI and Count]
    • Myeloma (Male) [CI and Count]
    • Myeloma (Female) [CI and Count]
    • Non-Hodgkin Lymphoma (Both Sexes) [CI and Count]
    • Non-Hodgkin Lymphoma (Male) [CI and Count]
    • Non-Hodgkin Lymphoma (Female) [CI and Count]
    • Nose, Nasal Cavity and Middle Ear (Both Sexes) [CI and Count]
    • Nose, Nasal Cavity and Middle Ear (Male) [CI and Count]
    • Nose, Nasal Cavity and Middle Ear (Female) [CI and Count]
    • Oral Cavity and Pharynx (Both Sexes) [CI and Count]
    • Oral Cavity and Pharynx (Male) [CI and Count]
    • Oral Cavity and Pharynx (Female) [CI and Count]
    • Floor of Mouth (Both Sexes) [CI and Count]
    • Floor of Mouth (Male) [CI and Count]
    • Floor of Mouth (Female) [CI and Count]
    • Gum and Other Mouth (Both Sexes) [CI and Count]
    • Gum and Other Mouth (Male) [CI and Count]
    • Gum and Other Mouth (Female) [CI and Count]
    • Lip (Both Sexes) [CI and Count]
    • Lip (Male) [CI and Count]
    • Lip (Female) [CI and Count]
    • Oropharynx and Tonsil (Both Sexes) [CI and Count]
    • Oropharynx and Tonsil (Male) [CI and Count]
    • Oropharynx and Tonsil (Female) [CI and Count]
    • Salivary Gland (Both Sexes) [CI and Count]
    • Salivary Gland (Male) [CI and Count]
    • Salivary Gland (Female) [CI and Count]
    • Tongue (Both Sexes) [CI and Count]
    • Tongue (Male) [CI and Count]
    • Tongue (Female) [CI and Count]
    • Ovary (Female) [CI and Count]
    • Pancreas (Both Sexes) [CI and Count]
    • Pancreas (Male) [CI and Count]
    • Pancreas (Female) [CI and Count]
    • Penis (Male) [CI and Count]
    • Prostate (Male) [CI and Count]
    • Small Intestine (Both Sexes) [CI and Count]
    • Small Intestine (Male) [CI and Count]
    • Small Intestine (Female) [CI and Count]
    • Soft Tissue including Heart (Both Sexes) [CI and Count]
    • Soft Tissue including Heart (Male) [CI and Count]
    • Soft Tissue including Heart (Female) [CI and Count]
    • Stomach (Both Sexes) [CI and Count]
    • Stomach (Male) [CI and Count]
    • Stomach (Female) [CI and Count]
    • Testis (Male) [CI and Count]
    • Thyroid (Both Sexes) [CI and Count]
    • Thyroid (Male) [CI and Count]
    • Thyroid (Female) [CI and Count]
    • Vagina (Female) [CI and Count]
    • Vulva (Female) [CI and Count]
    • Miscellaneous Malignant Cancer (Both Sexes) [CI and Count]
    • Miscellaneous Malignant Cancer (Male) [CI and Count]
    • Miscellaneous Malignant Cancer (Female) [CI and Count]
    • All Causes of Death (Both Sexes) [Rate per 100,000]
    • All Causes of Death (Male) [Rate per 100,000]
    • All Causes of Death (Female) [Rate per 100,000]
    • All Malignant Cancers (Both Sexes) [Rate per 100,000]
    • All Malignant Cancers (Male) [Rate per 100,000]
    • All Malignant Cancers (Female) [Rate per 100,000]
    • Anus, Anal Canal & Anorectum (Both Sexes) [Rate per 100,000]
    • Anus, Anal Canal & Anorectum (Male) [Rate per 100,000]
    • Anus, Anal Canal & Anorectum (Female) [Rate per 100,000]
    • Bladder (Both Sexes) [Rate per 100,000]
    • Bladder (Male) [Rate per 100,000]
    • Bladder (Female) [Rate per 100,000]
    • Bones and Joints (Both Sexes) [Rate per 100,000]
    • Bones and Joints (Male) [Rate per 100,000]
    • Bones and Joints (Female) [Rate per 100,000]
    • Brain and Other Nervous System (Both Sexes) [Rate per 100,000]
    • Brain and Other Nervous System (Male) [Rate per 100,000]
    • Brain and Other Nervous System (Female) [Rate per 100,000]
    • Breast (Female) [Rate per 100,000]
    • Cervix Uteri (Female) [Rate per 100,000]
    • Childhood (Ages <15) (Both Sexes) [Rate per 100,000]
    • Childhood (Ages <15) (Male) [Rate per 100,000]
    • Childhood (Ages <15) (Female) [Rate per 100,000]
    • Childhood (Ages <20) (Both Sexes) [Rate per 100,000]
    • Childhood (Ages <20) (Male) [Rate per 100,000]
    • Childhood (Ages <20) (Female) [Rate per 100,000]
    • Colon and Rectum (Both Sexes) [Rate per 100,000]
    • Colon and Rectum (Male) [Rate per 100,000]
    • Colon and Rectum (Female) [Rate per 100,000]
    • Colon (Both Sexes) [Rate per 100,000]
    • Colon (Male) [Rate per 100,000]
    • Colon (Female) [Rate per 100,000]
    • Rectum (and Rectosigmoid) (Both Sexes) [Rate per 100,000]
    • Rectum (and Rectosigmoid) (Male) [Rate per 100,000]
    • Rectum (and Rectosigmoid) (Female) [Rate per 100,000]
    • Corpus and Uterus,NOS (Female) [Rate per 100,000]
    • Esophagus (Both Sexes) [Rate per 100,000]
    • Esophagus (Male) [Rate per 100,000]
    • Esophagus (Female) [Rate per 100,000]
    • Eye and Orbit (Both Sexes) [Rate per 100,000]
    • Eye and Orbit (Male) [Rate per 100,000]
    • Eye and Orbit (Female) [Rate per 100,000]
    • Gallbladder (Both Sexes) [Rate per 100,000]
    • Gallbladder (Male) [Rate per 100,000]
    • Gallbladder (Female) [Rate per 100,000]
    • Hodgkin Lymphoma (Both Sexes) [Rate per 100,000]
    • Hodgkin Lymphoma (Male) [Rate per 100,000]
    • Hodgkin Lymphoma (Female) [Rate per 100,000]
    • Kidney and Renal Pelvis (Both Sexes) [Rate per 100,000]
    • Kidney and Renal Pelvis (Male) [Rate per 100,000]
    • Kidney and Renal Pelvis (Female) [Rate per 100,000]
    • Larynx (Both Sexes) [Rate per 100,000]
    • Larynx (Male) [Rate per 100,000]
    • Larynx (Female) [Rate per 100,000]
    • Leukemia: Total (Both Sexes) [Rate per 100,000]
    • Leukemia: Total (Male) [Rate per 100,000]
    • Leukemia: Total (Female) [Rate per 100,000]
    • Lymphocytic Leukemia (Both Sexes) [Rate per 100,000]
    • Lymphocytic Leukemia (Male) [Rate per 100,000]
    • Lymphocytic Leukemia (Female) [Rate per 100,000]
    • Acute Lymphocytic Leukemia (Both Sexes) [Rate per 100,000]
    • Acute Lymphocytic Leukemia (Male) [Rate per 100,000]
    • Acute Lymphocytic Leukemia (Female) [Rate per 100,000]
    • Chronic Lymphocytic Leukemia (Both Sexes) [Rate per 100,000]
    • Chronic Lymphocytic Leukemia (Male) [Rate per 100,000]
    • Chronic Lymphocytic Leukemia (Female) [Rate per 100,000]
    • Myeloid and Moncytic Leukemia (Both Sexes) [Rate per 100,000]
    • Myeloid and Moncytic Leukemia (Male) [Rate per 100,000]
    • Myeloid and Moncytic Leukemia (Female) [Rate per 100,000]
    • Acute Moncytic Leukemia (Both Sexes) [Rate per 100,000]
    • Acute Moncytic Leukemia (Male) [Rate per 100,000]
    • Acute Moncytic Leukemia (Female) [Rate per 100,000]
    • Acute Myeloid Leukemia (Both Sexes) [Rate per 100,000]
    • Acute Myeloid Leukemia (Male) [Rate per 100,000]
    • Acute Myeloid Leukemia (Female) [Rate per 100,000]
    • Chronic Myeloid Leukemia (Both Sexes) [Rate per 100,000]
    • Chronic Myeloid Leukemia (Male) [Rate per 100,000]
    • Chronic Myeloid Leukemia (Female) [Rate per 100,000]
    • Liver and Intrahepatic Bile Duct (Both Sexes) [Rate per 100,000]
    • Liver and Intrahepatic Bile Duct (Male) [Rate per 100,000]
    • Liver and Intrahepatic Bile Duct (Female) [Rate per 100,000]
    • Lung and Bronchus (Both Sexes) [Rate per 100,000]
    • Lung and Bronchus (Male) [Rate per 100,000]
    • Lung and Bronchus (Female) [Rate per 100,000]
    • Melanoma of the Skin (Both Sexes) [Rate per 100,000]
    • Melanoma of the Skin (Male) [Rate per 100,000]
    • Melanoma of the Skin (Female) [Rate per 100,000]
    • Myeloma (Both Sexes) [Rate per 100,000]
    • Myeloma (Male) [Rate per 100,000]
    • Myeloma (Female) [Rate per 100,000]
    • Non-Hodgkin Lymphoma (Both Sexes) [Rate per 100,000]
    • Non-Hodgkin Lymphoma (Male) [Rate per 100,000]
    • Non-Hodgkin Lymphoma (Female) [Rate per 100,000]
    • Nose, Nasal Cavity and Middle Ear (Both Sexes) [Rate per 100,000]
    • Nose, Nasal Cavity and Middle Ear (Male) [Rate per 100,000]
    • Nose, Nasal Cavity and Middle Ear (Female) [Rate per 100,000]
    • Oral Cavity and Pharynx (Both Sexes) [Rate per 100,000]
    • Oral Cavity and Pharynx (Male) [Rate per 100,000]
    • Oral Cavity and Pharynx (Female) [Rate per 100,000]
    • Floor of Mouth (Both Sexes) [Rate per 100,000]
    • Floor of Mouth (Male) [Rate per 100,000]
    • Floor of Mouth (Female) [Rate per 100,000]
    • Gum and Other Mouth (Both Sexes) [Rate per 100,000]
    • Gum and Other Mouth (Male) [Rate per 100,000]
    • Gum and Other Mouth (Female) [Rate per 100,000]
    • Lip (Both Sexes) [Rate per 100,000]
    • Lip (Male) [Rate per 100,000]
    • Lip (Female) [Rate per 100,000]
    • Oropharynx and Tonsil (Both Sexes) [Rate per 100,000]
    • Oropharynx and Tonsil (Male) [Rate per 100,000]
    • Oropharynx and Tonsil (Female) [Rate per 100,000]
    • Salivary Gland (Both Sexes) [Rate per 100,000]
    • Salivary Gland (Male) [Rate per 100,000]
    • Salivary Gland (Female) [Rate per 100,000]
    • Tongue (Both Sexes) [Rate per 100,000]
    • Tongue (Male) [Rate per 100,000]
    • Tongue (Female) [Rate per 100,000]
    • Ovary (Female) [Rate per 100,000]
    • Pancreas (Both Sexes) [Rate per 100,000]
    • Pancreas (Male) [Rate per 100,000]
    • Pancreas (Female) [Rate per 100,000]
    • Penis (Male) [Rate per 100,000]
    • Prostate (Male) [Rate per 100,000]
    • Small Intestine (Both Sexes) [Rate per 100,000]
    • Small Intestine (Male) [Rate per 100,000]
    • Small Intestine (Female) [Rate per 100,000]
    • Soft Tissue including Heart (Both Sexes) [Rate per 100,000]
    • Soft Tissue including Heart (Male) [Rate per 100,000]
    • Soft Tissue including Heart (Female) [Rate per 100,000]
    • Stomach (Both Sexes) [Rate per 100,000]
    • Stomach (Male) [Rate per 100,000]
    • Stomach (Female) [Rate per 100,000]
    • Testis (Male) [Rate per 100,000]
    • Thyroid (Both Sexes) [Rate per 100,000]
    • Thyroid (Male) [Rate per 100,000]
    • Thyroid (Female) [Rate per 100,000]
    • Vagina (Female) [Rate per 100,000]
    • Vulva (Female) [Rate per 100,000]
    • Miscellaneous Malignant Cancer (Both Sexes) [Rate per 100,000]
    • Miscellaneous Malignant Cancer (Male) [Rate per 100,000]
    • Miscellaneous Malignant Cancer (Female) [Rate per 100,000]

    Source:

    National Vital Statistics System. Rates are age-adjusted to the 2000 US standard population using SEER*Stat.

    Suppressed / Not Available:

    Data are suppressed if the total count < 16 for the time period.

Return to Top


Prevalence:

  • US by State 2017


  • Data is available for the following year groups:

    • 5-Year Projected Count
    • Complete Projected Count

    Data for the following variables is available for each year group:

    • All Cancers (Female)
    • Breast Cancer (Female)
    • All Cancers (Male)

    Source:

    Single age and year state specific mortality data for cancer and all causes of death from the National Center for Health Statistics (NCHS), and respective populations from the US Census Bureau, are available for calendar years 1969-2007 from SEER*Stat. The population projections were obtained from the US Census Bureau.

    Suppressed / Not Available:

    Data is shown if it is available.

Return to Top


Screening and Risk Factors:

  • US by State 2018


  • Data is available for the following topic and variable combinations:

    • Colorectal Screening
      • Ever Had Colorectal Endoscopy (Sigmoidoscopy or Colonoscopy) (Ages 50+, Both Sexes, 2016) [Percent] )
      • Ever Had Colorectal Endoscopy (Sigmoidoscopy or Colonoscopy) (Ages 50+, Males, 2016) [Percent] )
      • Ever Had Colorectal Endoscopy (Sigmoidoscopy or Colonoscopy) (Ages 50+, Females, 2016) [Percent] )
      • FOBT in last year and/or flex sig in last 5 years and FOBT in last 3 years and/or colonoscopy in last 10 years (Ages 50-75, Males, 2016) [Percent] )
      • FOBT in last year and/or flex sig in last 5 years and FOBT in last 3 years and/or colonoscopy in last 10 years (Ages 50-75, Both Sexes, 2016) [Percent] )
      • FOBT in last year and/or flex sig in last 5 years and FOBT in last 3 years and/or colonoscopy in last 10 years (Ages 50-75, Females, 2016) [Percent] )
      • Home-Based Fecal Occult Blood Test (FOBT) in Past Two Years (Ages 50+, Both Sexes, 2016) [Percent] )
      • Home-Based Fecal Occult Blood Test (FOBT) in Past Two Years (Ages 50+, Females, 2016) [Percent] )
      • Home-Based Fecal Occult Blood Test (FOBT) in Past Two Years (Ages 50+, Males, 2016) [Percent] )
      • Home-based FOBT in the past two years or ever had a colorectal endoscopy (Ages 50+, Both Sexes, 2016) [Percent] )
      • Home-based FOBT in the past two years or ever had a colorectal endoscopy (Ages 50+, Females, 2016) [Percent] )
      • Home-based FOBT in the past two years or ever had a colorectal endoscopy (Ages 50+, Males, 2016) [Percent] )
    • Diet and Exercise
      • Consumed 1 or More Fruits per Day (Ages 18+, Males, 2015) [Percent] )
      • Consumed 1 or More Fruits per Day (Ages 18+, Females, 2015) [Percent] )
      • Consumed 1 or More Fruits per Day (Ages 18+, Both Sexes, 2015) [Percent] )
      • Consumed 1 or More Vegetables per Day (Ages 18+, Females, 2015) [Percent] )
      • Consumed 1 or More Vegetables per Day (Ages 18+, Both Sexes, 2015) [Percent] )
      • Consumed 1 or More Vegetables per Day (Ages 18+, Males, 2015) [Percent] )
      • Healthy Weight (BMI 18.5 to <25) (Ages 20+, Males, 2016) [Percent] )
      • Healthy Weight (BMI 18.5 to <25) (Ages 20+, Both Sexes, 2016) [Percent] )
      • Healthy Weight (BMI 18.5 to <25) (Ages 20+, Females, 2016) [Percent] )
      • No Leisure Time Physical Activity (Ages 18+, Both Sexes, 2016) [Percent] )
      • No Leisure Time Physical Activity (Ages 18+, Males, 2016) [Percent] )
      • No Leisure Time Physical Activity (Ages 18+, Females, 2016) [Percent] )
      • Obese (>= 95th percentile for BMI based on sex and age) (High School Students, Males, 2015) [Percent] )
      • Obese (>= 95th percentile for BMI based on sex and age) (High School Students, Both Sexes, 2015) [Percent] )
      • Obese (>= 95th percentile for BMI based on sex and age) (High School Students, Females, 2015) [Percent] )
      • Obese (BMI >= 30) (Ages 20+, Males, 2016) [Percent] )
      • Obese (BMI >= 30) (Ages 20+, Both Sexes, 2016) [Percent] )
      • Obese (BMI >= 30) (Ages 20+, Females, 2016) [Percent] )
      • Overweight (>= 85th percentile but <95th percentile for BMI based on sex and age) (High School Students, Both Sexes, 2015) [Percent] )
      • Overweight (>= 85th percentile but <95th percentile for BMI based on sex and age) (High School Students, Females, 2015) [Percent] )
      • Overweight (>= 85th percentile but <95th percentile for BMI based on sex and age) (High School Students, Males, 2015) [Percent] )
    • Smoking
      • Current Smokers (Ages 18+, Both Sexes, 2016) [Percent]
      • Current Smokers (Ages 18+, Females, 2016) [Percent]
      • Current Smokers (Ages 18+, Males, 2016) [Percent]
      • Ever Smoked (Ages 18+, Both Sexes, 2016) [Percent]
      • Ever Smoked (Ages 18+, Females, 2016) [Percent]
      • Ever Smoked (Ages 18+, Males, 2016) [Percent]
    • Women's Health
      • Had a Mammogram in Past 2 Years (Ages 50-74, Females, 2016) [Percent] )
      • Had a Mammogram in Past 2 Years (Ages 40+, Females, 2016) [Percent] )
      • Had a Pap Smear in Past 3 Years and No Hysterectomy (Ages 18+, Females, 2016) [Percent] )
      • Pap Test in Past 3 Years, No Hysterectomy (Ages 21-65, Females, 2016) [Percent] )
      • Percent who received 3+ doses of HPV Vaccine (Ages 13-15, Both Sexes, 2016) [Percent] )
      • Percent who received 3+ doses of HPV Vaccine (Ages 13-15, Males, 2016) [Percent] )
      • Percent who received 3+ doses of HPV Vaccine (Ages 13-15, Females, 2016) [Percent] )
      • Percent who received 3+ doses of HPV Vaccine (Ages 13-17, Both Sexes, 2016) [Percent] )
      • Percent who received 3+ doses of HPV Vaccine (Ages 13-17, Males, 2016) [Percent] )
      • Percent who received 3+ doses of HPV Vaccine (Ages 13-17, Females, 2016) [Percent] )

    Source:

    Source: These data are from the BRFSS and YRBSS from different years and from the National Immunization Survey.

    Suppressed / Not Available:

    Data is shown if it is available.


  • US County


  • Data is available for the following topic and variable combinations:

    • County level UV Exposure Data
      • UV Exposure Data [Watt-Hours Per Square Meter]

      Source:

      Source: These data are from the GIS.CANCER.GOV website.

      Suppressed / Not Available:

      Data is not available for Alaska or Hawaii.

    Return to Top


    Support Data:

    • US Population by County 2012

    • US Population by HSA 2012

    • US Population by SEA 2012

    • US Population by State 2012


    • Data for the following variables is available for All Races:

      • Male Population: 00 - 04 (Count)
      • Male Population: 05 - 09 (Count)
      • Male Population: 10 - 14 (Count)
      • Male Population: 15 - 19 (Count)
      • Male Population: 20 - 24 (Count)
      • Male Population: 25 - 29 (Count)
      • Male Population: 30 - 34 (Count)
      • Male Population: 35 - 39 (Count)
      • Male Population: 40 - 44 (Count)
      • Male Population: 45 - 49 (Count)
      • Male Population: 50 - 54 (Count)
      • Male Population: 55 - 59 (Count)
      • Male Population: 60 - 64 (Count)
      • Male Population: 65 - 69 (Count)
      • Male Population: 70 - 74 (Count)
      • Male Population: 75 - 79 (Count)
      • Male Population: 80 - 84 (Count)
      • Male Population: 85+ (Count)
      • Female Population: 00 - 04 (Count)
      • Female Population: 05 - 09 (Count)
      • Female Population: 10 - 14 (Count)
      • Female Population: 15 - 19 (Count)
      • Female Population: 20 - 24 (Count)
      • Female Population: 25 - 29 (Count)
      • Female Population: 30 - 34 (Count)
      • Female Population: 35 - 39 (Count)
      • Female Population: 40 - 44 (Count)
      • Female Population: 45 - 49 (Count)
      • Female Population: 50 - 54 (Count)
      • Female Population: 55 - 59 (Count)
      • Female Population: 60 - 64 (Count)
      • Female Population: 65 - 69 (Count)
      • Female Population: 70 - 74 (Count)
      • Female Population: 75 - 79 (Count)
      • Female Population: 80 - 84 (Count)
      • Female Population: 85+ (Count)

      Source:

      Census Bureau adjusted population file.

    Return to Top